Author

Mourad Tayebi

WSU - Cited by 1,666 - Neuroscience - Neuroimmunology - prion - Alzheimer's - Parkinson

Biography

Dr. is currently working at Pharmacy Department. Dr. is research interests includes Pharmacy in Biotechnology. Dr. serving as an editorial member and reviewer of several international reputed journals. Dr. has successfully completed his Administrative responsibilities. Dr. has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro
C Bate, M Tayebi, A WilliamsMolecular Neurodegeneration 3 (1), 1-9, 2008200
82
2008
A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines
DR Jones, WA Taylor, C Bate, M David, M TayebiPloS one 5 (3), e9804, 2010201
50
2010
Phospholipase A2inhibitors protect against prion and Aβ mediated synapse degeneration
C Bate, M Tayebi, A WilliamsMolecular neurodegeneration 5, 1-12, 2010201
48
2010
Potential candidate camelid antibodies for the treatment of protein-misfolding diseases
MA David, DR Jones, M TayebiJournal of Neuroimmunology 272 (1-2), 76-85, 2014201
38
2014
Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity
C Bate, M Tayebi, L Diomede, M Salmona, A WilliamsPLoS One 4 (12), e8221, 2009200
33
2009
Immunohistochemical validation of spontaneously arising canine osteosarcoma as a model for human osteosarcoma
AA Al-Khan, HJ Gunn, MJ Day, M Tayebi, SD Ryan, CA Kuntz, ES Saad, ...Journal of comparative pathology 157 (4), 256-5, 2017201
26
2017
Unswitched immunoglobulin M response prolongs mouse survival in prion disease
M Tayebi, J Collinge, S HawkeJournal of general virology 90 (3), 777-782, 2009200
25
2009
The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication
C Bate, M Tayebi, A WilliamsBiochemical Journal 428 (1), 95-101, 2010201
25
2010
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ...Database 19, 191
20
2019
PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers
M Tayebi, DR Jones, WA Taylor, BF Stileman, C Chapman, D Zhao, ...PLoS One 6 (5), e19998, 111
20
2011
Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
C Bate, M Tayebi, L Diomede, M Salmona, A WilliamsBMC biology 6 (1), 1-12, 2008200
19
2008
Canine mixed mammary tumour as a model for human breast cancer with osseous metaplasia
ES Saad, KM Milley, AA Al-Khan, JS Nimmo, B Bacci, M Tayebi, MJ Day, ...Journal of comparative pathology 156 (4), 352-365, 2017201
18
2017
Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation
C Bate, M Tayebi, A WilliamsJournal of Biological Chemistry 285 (29), 220-22026, 2010201
17
2010
Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro
C Bate, M Tayebi, M Salmona, L Diomede, A WilliamsNeurotoxicity research , 203-214, 2010201
17
2010
An aged canid with behavioral deficits exhibits blood and cerebrospinal fluid amyloid beta oligomers
C Rusbridge, FJ Salguero, MA David, KME Faller, JT Bras, RJ Guerreiro, ...Frontiers in aging neuroscience 10, 7, 2018201
15
2018
Cholesterol esterification reduces the neurotoxicity of prions
C Bate, M Tayebi, A WilliamsNeuropharmacology 54 (8), 1247-1253, 2008200
13
2008
Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases
M Tayebi, S HawkeImmunology letters 105 (2), 123-126, 2006200
11
2006